Age-dependent sensitivity of the lamb ductus arteriosus to indomethacin and prostaglandins
- PMID: 6985662
- DOI: 10.1016/s0022-3476(80)80338-6
Age-dependent sensitivity of the lamb ductus arteriosus to indomethacin and prostaglandins
Abstract
Endogenous prostaglandins inhibit the ability of the ductus arteriosus to contract in response to oxygen. We studied the effects of endogenous prostaglandins and indomethacin (an inhibitor of endogenous prostaglandin production) on isometric contraction of isolated rings of lamb ductus arteriosus from animals of different gestational ages (98 to 103 days and 136 to 147 days; term is 150 days). Rings from animals at about 100 days' gestation have a significantly larger indomethacin-induced contraction than rings from animals near term. The lamb ductus arteriosus forms two prostaglandins that relax the vessel: postaglandin E2 and prostacyclin. PGI2 was three orders of magnitude less potent than PGE2. Rings from the younger animals were significantly more sensitive to the relaxing action of PGE2 and PGI2 than were rings from animals near term. This increased sensitivity of immature animals to endogenous prostaglandins is consistent with the more potent effect of indomethacin on rings from immature animals. These observations are also consistent with the findings that preterm infants have an increased incidence of patent ductus arteriosus and that indomethacin can constrict the ductus arteriosus in preterm infants.
Similar articles
-
PGE2 is a more potent vasodilator of the lamb ductus arteriosus than is either PGI2 or 6 keto PGF1alpha.Prostaglandins. 1978 Aug;16(2):259-64. doi: 10.1016/0090-6980(78)90028-x. Prostaglandins. 1978. PMID: 360304
-
Developmental response to indomethacin: a comparison of isometric tension with PGE2 formation in the lamb ductus arteriosus.Prostaglandins. 1979 Nov;18(5):721-30. doi: 10.1016/0090-6980(79)90092-3. Prostaglandins. 1979. PMID: 542609
-
Formation of prostacyclin (PGI2) by the ductus arteriosus of fetal lambs at different stages of gestation.Prostaglandins. 1978 Oct;16(4):633-42. doi: 10.1016/0090-6980(78)90193-4. Prostaglandins. 1978. PMID: 364551
-
Ontogeny of the ductus arteriosus response to prostaglandins and inhibitors of their synthesis.Semin Perinatol. 1980 Apr;4(2):115-24. Semin Perinatol. 1980. PMID: 6990502 Review. No abstract available.
-
Patent ductus arteriosus. Clinical relevance of prostaglandins and prostaglandin inhibitors in PDA pathophysiology and treatment.Clin Perinatol. 1995 Jun;22(2):457-79. Clin Perinatol. 1995. PMID: 7671547 Review.
Cited by
-
Potential Unintended Consequences of a Conservative Management Strategy for Patent Ductus Arteriosus.Congenit Heart Dis. 2016 Jan-Feb;11(1):52-7. doi: 10.1111/chd.12287. Epub 2015 Jul 20. Congenit Heart Dis. 2016. PMID: 26193967 Free PMC article.
-
Patent ductus arteriosus in preterm infants: is early transcatheter closure a paradigm shift?J Perinatol. 2019 Nov;39(11):1449-1461. doi: 10.1038/s41372-019-0506-7. Epub 2019 Sep 27. J Perinatol. 2019. PMID: 31562396 Review.
-
Echocardiographic flow pattern of patent ductus arteriosus: a guide to indomethacin treatment in premature infants.Arch Dis Child Fetal Neonatal Ed. 1999 Nov;81(3):F197-200. doi: 10.1136/fn.81.3.f197. Arch Dis Child Fetal Neonatal Ed. 1999. PMID: 10525023 Free PMC article. Clinical Trial.
-
Sulforaphane inhibits prostaglandin E2 synthesis by suppressing microsomal prostaglandin E synthase 1.PLoS One. 2012;7(11):e49744. doi: 10.1371/journal.pone.0049744. Epub 2012 Nov 16. PLoS One. 2012. PMID: 23166763 Free PMC article.
-
Prostaglandin E1 responsive ductus at 11 months of age.Pediatr Cardiol. 1984 Jan-Mar;5(1):19-21. doi: 10.1007/BF02306743. Pediatr Cardiol. 1984. PMID: 6540441
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources